Advisory - Multiple lots of irbesartan, losartan and valsartan drugs recalled due to azido impurity

OTTAWA, ON, Aug. 28, 2021 /CNW/ -

Summary

• Products: Irbesartan, losartan and valsartan drugs
• Issue: Several companies are recalling multiple lots of these products due to the presence of an azido impurity
• What to do: Continue taking your medication unless you have been advised to stop by your healthcare provider. Not treating your condition may pose a greater health risk.

Issue
UPDATE (August 28, 2021): Certain lots of Teva-Losartan and Sivem-Losartan recalled due to azido impurity

Teva Canada Ltd. and Sivem Pharmaceuticals ULC are recalling a total of 7 lots of prescription losartan tablets, in 25mg, 50mg and 100 mg strengths, after tests found an azido impurity (5-(4'-((5-(azidomethyl)-2-butyl-4-chloro-1H imidazol-1-yl)methyl)-[1,1'-biphenyl]-2-yl)-1H tetrazole) above the acceptable limit.

As with the different azido impurity that Health Canada communicated about on May 30, 2021 (see below), long-term exposure to levels above what is considered safe could potentially increase the risk of cancer.

Refer to the Affected Products table below for information on the recalled lots, and to the section below on what you should do. Should additional recalls be necessary, Health Canada will update the list of affected products and inform Canadians.

UPDATE (June 15, 2021): sanofi-aventis Canada Inc. recalls 12 lots of irbesartan drugs due to azido impurity

sanofi-aventis Canada Inc. is recalling 12 lots of prescription irbesartan tablets (brand names Avalide and Avapro, in various strengths) after tests found the azido impurity above the acceptable limit. Refer to the Affected Products table below for detailed information on the recalled lots.

Should additional recalls be necessary, Health Canada will update the list of affected products and inform Canadians.

Original Advisory (May 30, 2021): Multiple lots of irbesartan, losartan and valsartan drugs recalled due to azido impurity

Health Canada is informing Canadians that several companies are recalling multiple lots of irbesartan, losartan and valsartan drug products after tests found an azido impurity above the acceptable limit (see list of affected products below).

Irbesartan, losartan and valsartan are all prescription angiotensin receptor blocker (ARB) drugs, which are also known as "sartans." Sartans are a class of drugs used to treat patients with high blood pressure to help prevent heart attacks and stroke. They are also used in patients with heart failure or those who have had a recent heart attack.

The azido impurity, 5-(4'-(azidomethyl)-[1,1'-biphenyl]-2yl)-1H-tetrazole, is considered a mutagen. A mutagen is a chemical substance that can cause a change in the DNA of a cell. These mutations may increase the risk of cancer but the specific risk for this azido impurity to cause cancer in humans is unknown.

There are established international guidelines that recommend that mutagenic impurities be kept at or below a specific level because exposure to a mutagen over the long term at a level above what is considered to be safe, has the potential to increase the risk of cancer. A person taking a drug daily for 70 years that contains this azido impurity at or below the acceptable level is not expected to have an increased risk of cancer.

Not all lots of irbesartan, losartan and valsartan from these companies are affected by this issue; however, it is possible that the recalls may affect the supply of some products. Patients should speak with their doctor or pharmacist to discuss alternatives should their regular prescribed drug not be available.

The Department expects manufacturers to take any necessary actions to reduce or eliminate the azido impurity. Impacted companies have been directed to implement control measures to ensure that the level of the impurity in their products are at or below the acceptable level. Health Canada is monitoring the effectiveness of the recalls. Should additional recalls be deemed necessary, Health Canada will inform Canadians.

What you should do

• Continue taking your medication unless you have been advised to stop by your healthcare provider. There is no immediate risk to patients taking these medications, since the potential increased risk of cancer is with long-term exposure to the impurity. Not treating your condition may pose a greater health risk.
• If you have been using an affected product, contact your healthcare provider as soon as possible to discuss treatment options. Pharmacists may be able to provide a product not affected by the recall, or your doctor may prescribe a different medication for your condition.
• Report any health product side effects or complaints to Health Canada.
• Contact the company directly if you have questions about a recall:
• Auro Pharma Inc. by calling toll free at 1-855-568-2511, or by email at [email protected]
• Mint Pharmaceuticals Inc. by calling 1-905-795-9437, extension 2201, or by email at [email protected] 
• Pharmascience Inc. by calling toll free at 1-800-340-9735
• Pro Doc Ltd. by calling toll free at 1-800-361-8559
• sanofi-aventis Canada Inc. by calling toll free at 1–800-265-7927
• Sandoz Canada Inc. by calling toll free at 1-800-343-8839
• Sanis Health Inc. by calling toll free at 1-866-236-4076, or by email at [email protected]
• Sivem Pharmaceuticals ULC by calling toll free at 1-855-757-4836
• Sun Pharma Canada Inc. by calling toll free at 1-800-268-1975, or by email at [email protected]
• Teva Canada Ltd. by calling toll free at 1-800-268-4129

Affected products
Products are listed alphabetically by name.

Product	Company	DIN	Lot	Expiry	Date Added
Irbesartan
AVALIDE 150-12.5 mg TABLETS	sanofi-aventis Canada Inc.	02241818	ET02879	June 2021	June 15, 2021
AVALIDE 150-12.5 mg TABLETS	sanofi-aventis Canada Inc.	02241818	FT01327	December 2021	June 15, 2021
AVALIDE 300-12.5 mg TABLETS	sanofi-aventis Canada Inc.	02241819	FT01644	February 2022	June 15, 2021
AVAPRO 75 mg TABLETS	sanofi-aventis Canada Inc.	02237923	FT00590	October 2021	June 15, 2021
AVAPRO 150 mg TABLETS	sanofi-aventis Canada Inc.	02237924	FT01238	January 2022	June 15, 2021
AVAPRO 150 mg TABLETS	sanofi-aventis Canada Inc.	02237924	ET04153	August 2021	June 15, 2021
AVAPRO 150 mg TABLETS	sanofi-aventis Canada Inc.	02237924	FT01995	March 2022	June 15, 2021
AVAPRO 300 mg TABLETS	sanofi-aventis Canada Inc.	02237925	FT00969	January 2022	June 15, 2021
AVAPRO 300 mg TABLETS	sanofi-aventis Canada Inc.	02237925	FT01225	January 2022	June 15, 2021
AVAPRO 300 mg TABLETS	sanofi-aventis Canada Inc.	02237925	FT01226	January 2022	June 15, 2021
AVAPRO 300 mg TABLETS	sanofi-aventis Canada Inc.	02237925	FT01999	March 2022	June 15, 2021
AVAPRO 300 mg TABLETS	sanofi-aventis Canada Inc.	02237925	FT04262	July 2022	June 15, 2021
IRBESARTAN 150 mg TABLETS	Pro Doc Ltd.	02365200	617491	July 2021	May 30, 2021
IRBESARTAN 150 mg TABLETS	Pro Doc Ltd.	02365200	618112	March 2022	May 30, 2021
IRBESARTAN 150 mg TABLETS	Pro Doc Ltd.	02365200	624632	January 2023	May 30, 2021
IRBESARTAN 150 mg TABLETS	Pro Doc Ltd.	02365200	624633	January 2023	May 30, 2021
IRBESARTAN 150 mg TABLETS	Pro Doc Ltd.	02365200	630546	May 2023	May 30, 2021
IRBESARTAN 300 mg TABLETS	Pro Doc Ltd.	02365219	615929	June 2021	May 30, 2021
IRBESARTAN 300 mg TABLETS	Pro Doc Ltd.	02365219	617091	June 2021	May 30, 2021
IRBESARTAN 300 mg TABLETS	Pro Doc Ltd.	02365219	617264	June 2021	May 30, 2021
IRBESARTAN 300 mg TABLETS	Pro Doc Ltd.	02365219	620694	March 2022	May 30, 2021
IRBESARTAN 300 mg TABLETS	Pro Doc Ltd.	02365219	624189	May 2022	May 30, 2021
IRBESARTAN 300 mg TABLETS	Pro Doc Ltd.	02365219	624190	May 2022	May 30, 2021
IRBESARTAN 300 mg TABLETS	Pro Doc Ltd.	02365219	624191	January 2023	May 30, 2021
IRBESARTAN 300 mg TABLETS	Pro Doc Ltd.	02365219	624192	January 2023	May 30, 2021
IRBESARTAN 75 mg TABLETS	Pro Doc Ltd.	02365197	616518	June 2021	May 30, 2021
IRBESARTAN 75 mg TABLETS	Pro Doc Ltd.	02365197	619960	November 2021	May 30, 2021
IRBESARTAN 75 mg TABLETS	Pro Doc Ltd.	02365197	622192	May 2022	May 30, 2021
IRBESARTAN 75 mg TABLETS	Pro Doc Ltd.	02365197	622193	December 2022	May 30, 2021
IRBESARTAN HCT/TABLET/150/12.5 mg	Sivem Pharmaceuticals ULC	02385317	JN5054	January 2022	May 30, 2021
IRBESARTAN HCT/TABLET/150/12.5 mg	Sivem Pharmaceuticals ULC	02385317	JV2163	April 2022	May 30, 2021
IRBESARTAN HCT/TABLET/150/12.5 mg	Sivem Pharmaceuticals ULC	02385317	JY7867	June 2022	May 30, 2021
IRBESARTAN HCT/TABLET/150/12.5 mg	Sivem Pharmaceuticals ULC	02385317	KT2519	May 2023	May 30, 2021
IRBESARTAN HCT/TABLET/150/12.5 mg	Sivem Pharmaceuticals ULC	02385317	KT2520	May 2023	May 30, 2021
IRBESARTAN HCT/TABLET/300/12.5 mg	Sivem Pharmaceuticals ULC	02385325	JP2979	January 2022	May 30, 2021
IRBESARTAN HCT/TABLET/300/12.5 mg	Sivem Pharmaceuticals ULC	02385325	JP2980	January 2022	May 30, 2021
IRBESARTAN HCT/TABLET/300/12.5 mg	Sivem Pharmaceuticals ULC	02385325	JU8206	April 2022	May 30, 2021
IRBESARTAN HCT/TABLET/300/12.5 mg	Sivem Pharmaceuticals ULC	02385325	JU8207	April 2022	May 30, 2021
IRBESARTAN H CT/TABLET/300/25 mg	Sivem Pharmaceuticals ULC	02385333	JX8881	June 2022	May 30, 2021
IRBESARTAN HCT/TABLET/300/25 mg	Sivem Pharmaceuticals ULC	02385333	JX8882	June 2022	May 30, 2021
IRBESARTAN HCT/TABLET/300/25 mg	Sivem Pharmaceuticals ULC	02385333	JB0216	May 2021	May 30, 2021
IRBESARTAN/TABLET/150 mg	Sivem Pharmaceuticals ULC	02385295	KC7215	July 2021	May 30, 2021
IRBESARTAN/TABLET/300 mg	Sivem Pharmaceuticals ULC	02385309	KF8325	July 2021	May 30, 2021
IRBESARTAN-HCTZ 150/12.5mg TABLETS	Pro Doc Ltd.	02365162	JN4976	January 2022	May 30, 2021
IRBESARTAN-HCTZ 150/12.5 mg TABLETS	Pro Doc Ltd.	02365162	JU3231	January 2022	May 30, 2021
IRBESARTAN-HCTZ 150/12.5 mg TABLETS	Pro Doc Ltd.	02365162	JY1913	June 2022	May 30, 2021
IRBESARTAN-HCTZ 300/12.5 mg TABLETS	Pro Doc Ltd.	02365170	HW0586	February 2021	May 30, 2021
IRBESARTAN-HCTZ 300/12.5 mg TABLETS	Pro Doc Ltd.	02365170	HW0587	February 2021	May 30, 2021
IRBESARTAN-HCTZ 300/12.5 mg TABLETS	Pro Doc Ltd.	02365170	JR7823	February 2022	May 30, 2021
IRBESARTAN-HCTZ 300/12.5 mg TABLETS	Pro Doc Ltd.	02365170	JR7824	February 2022	May 30, 2021
IRBESARTAN-HCTZ 300/12.5 mg TABLETS	Pro Doc Ltd.	02365170	JU7506	April 2022	May 30, 2021
IRBESARTAN-HCTZ 300/25 mg TABLETS	Pro Doc Ltd.	02365189	JS0731	February 2022	May 30, 2021
MINT- IRBESARTAN /HCTZ 150/12.5 mg TABLETS	Mint Pharmaceuticals Inc.	02392992	1805011398	August 2021	May 30, 2021
MINT- IRBESARTAN /HCTZ 300/12.5 mg TABLETS	Mint Pharmaceuticals Inc.	02393018	1805011402	August 2021	May 30, 2021
MINT- IRBESARTAN /HCTZ 300/25.0 mg TABLETS	Mint Pharmaceuticals Inc.	02393026	1805011576	August 2021	May 30, 2021
pms-IRBESARTAN 150 mg TABLETS	Pharmascience Inc.	02317079	617492	July 2021	May 30, 2021
pms-IRBESARTAN 150 mg TABLETS	Pharmascience Inc.	02317079	624634	January 2023	May 30, 2021
pms-IRBESARTAN 150 mg TABLETS	Pharmascience Inc.	02317079	630661	May 2023	May 30, 2021
pms-IRBESARTAN 75 mg TABLETS	Pharmascience Inc.	02317060	617466	November 2021	May 30, 2021
pms-IRBESARTAN 75 mg TABLETS	Pharmascience Inc.	02317060	617467	November 2021	May 30, 2021
pms-IRBESARTAN 75 mg TABLETS	Pharmascience Inc.	02317060	617468	November 2021	May 30, 2021
pms-IRBESARTAN 75 mg TABLETS	Pharmascience Inc.	02317060	620272	November 2021	May 30, 2021
pms-IRBESARTAN 75 mg TABLETS	Pharmascience Inc.	02317060	622195	December 2022	May 30, 2021
pms-IRBESARTAN 75 mg TABLETS	Pharmascience Inc.	02317060	624738	December 2022	May 30, 2021
pms-IRBESARTAN-HCTZ 300/12.5 mg TABLETS	Pharmascience Inc.	02328526	621822	July 2021	May 30, 2021
pms-IRBESARTAN-HCTZ 300/12.5 mg TABLETS	Pharmascience Inc.	02328526	621823	November 2021	May 30, 2021
pms-IRBESARTAN-HCTZ 300/12.5 mg TABLETS	Pharmascience Inc.	02328526	625318	February 2022	May 30, 2021
pms-IRBESARTAN-HCTZ 300/12.5 mg TABLETS	Pharmascience Inc.	02328526	625902	January 2022	May 30, 2021
pms-IRBESARTAN-HCTZ 300/12.5 mg TABLETS	Pharmascience Inc.	02328526	629920	July 2022	May 30, 2021
pms-IRBESARTAN-HCTZ 300/12.5 mg TABLETS	Pharmascience Inc.	02328526	631052	October 2022	May 30, 2021
pms-IRBESARTAN-HCTZ 300/12.5 mg TABLETS	Pharmascience Inc.	02328526	632583	November 2022	May 30, 2021
pms-IRBESARTAN-HCTZ 300/25 mg TABLETS	Pharmascience Inc.	02328534	624235	June 2021	May 30, 2021
RAN- IRBESARTAN Tablets 150 mg	Sun Pharma Canada Inc.	02406829	AB47146	April 2023	May 30, 2021
RAN- IRBESARTAN Tablets 150 mg	Sun Pharma Canada Inc.	02406829	AB47147	April 2023	May 30, 2021
RAN- IRBESARTAN Tablets 150 mg	Sun Pharma Canada Inc.	02406829	AB47148	April 2023	May 30, 2021
RAN- IRBESARTAN Tablets 150 m g	Sun Pharma Canada Inc.	02406829	AB57691	May 2023	May 30, 2021
RAN- IRBESARTAN Tablets 150 mg	Sun Pharma Canada Inc.	02406829	AB57688	May 2023	May 30, 2021
RAN- IRBESARTAN Tablets 150 mg	Sun Pharma Canada Inc.	02406829	AB57689	May 2023	May 30, 2021
RAN- IRBESARTAN Tablets 150 mg	Sun Pharma Canada Inc.	02406829	AB58827	May 2023	May 30, 2021
RAN- IRBESARTAN Tablets 150 mg	Sun Pharma Canada Inc.	02406829	3990655	November 2021	May 30, 2021
RAN- IRBESARTAN Tablets 300 mg	Sun Pharma Canada Inc.	02406837	AB47144	April 2023	May 30, 2021
RAN- IRBESARTAN Tablets 300 mg	Sun Pharma Canada Inc.	02406837	AB47145	April 2023	May 30, 2021
RAN- IRBESARTAN Tablets 300 mg	Sun Pharma Canada Inc.	02406837	AB58305	May 2023	May 30, 2021
RAN- IRBESARTAN Tablets 300 mg	Sun Pharma Canada Inc.	02406837	AB58304	May 2023	May 30, 2021
RAN- IRBESARTAN Tablets 300 mg	Sun Pharma Canada Inc.	02406837	AB58312	May 2023	May 30, 2021
RAN- IRBESARTAN Tablets 300 mg	Sun Pharma Canada Inc.	02406837	AB58314	May 2023	May 30, 2021
RAN- IRBESARTAN Tablets 300 mg	Sun Pharma Canada Inc.	02406837	AB58828	May 2023	May 30, 2021
RAN- IRBESARTAN Tablets 300 mg	Sun Pharma Canada Inc.	02406837	AB57696	May 2023	May 30, 2021
RAN- IRBESARTAN Tablets 300 mg	Sun Pharma Canada Inc.	02406837	AB70496	June 2023	May 30, 2021
RAN- IRBESARTAN Tablets 300 mg	Sun Pharma Canada Inc.	02406837	AB70498	June 2023	May 30, 2021
RAN- IRBESARTAN Tablets 300 mg	Sun Pharma Canada Inc.	02406837	AB70499	June 2023	May 30, 2021
RAN- IRBESARTAN Tablets 300 mg	Sun Pharma Canada Inc.	02406837	3991358	November 2021	May 30, 2021
RAN- IRBESARTAN Tablets 300 mg	Sun Pharma Canada Inc.	02406837	3991360	November 2021	May 30, 2021
RAN- IRBESARTAN Tablets 75 mg	Sun Pharma Canada Inc.	02406810	AB47143	April 2023	May 30, 2021
RAN- IRBESARTAN Tablets 75 mg	Sun Pharma Canada Inc.	02406810	AB58473	May 2023	May 30, 2021
RAN- IRBESARTAN Tablets 75 mg	Sun Pharma Canada Inc.	02406810	AB58829	May 2023	May 30, 2021
RAN- IRBESARTAN Tablets 75 mg	Sun Pharma Canada Inc.	02406810	3994101	November 2021	May 30, 2021
Sandoz IRBESARTAN 150 mg TABLETS	Sandoz Canada Inc.	02328488	KC7216	July 2021	May 30, 2021
Sandoz IRBESARTAN 300 mg TABLETS	Sandoz Canada Inc.	02328496	KF8326	July 2021	May 30, 2021
Sandoz IRBESARTAN HCT 150/12.5 mg TABLETS	Sandoz Canada Inc.	02337428	JF5840	August 2021	May 30, 2021
Sandoz IRBESARTAN HCT 150/12.5 mg TABLETS	Sandoz Canada Inc.	02337428	JN4197	January 2022	May 30, 2021
Sandoz IRBESARTAN HCT 150/12.5 mg TABLETS	Sandoz Canada Inc.	02337428	JN4971	January 2022	May 30, 2021
Sandoz IRBESARTAN HCT 150/12.5 mg TABLETS	Sandoz Canada Inc.	02337428	JU3217	January 2022	May 30, 2021
Sandoz IRBESARTAN HCT 150/12.5 mg TABLETS	Sandoz Canada Inc.	02337428	JV2167	April 2022	May 30, 2021
Sandoz IRBESARTAN HCT 150/12.5 mg TABLETS	Sandoz Canada Inc.	02337428	JF8892	August 2021	May 30, 2021
Sandoz IRBESARTAN HCT 150/12.5 mg TABLETS	Sandoz Canada Inc.	02337428	JN4191	January 2022	May 30, 2021
Sandoz IRBESARTAN HCT 300/12.5 mg TABLETS	Sandoz Canada Inc.	02337436	JA4033	February 2021	May 30, 2021
Sandoz IRBESARTAN HCT 300/12.5 mg TABLETS	Sandoz Canada Inc.	02337436	HY7383	May 2021	May 30, 2021
Sandoz IRBESARTAN HCT 300/12.5 mg TABLETS	Sandoz Canada Inc.	02337436	JA4034	May 2021	May 30, 2021
Sandoz IRBESARTAN HCT 300/12.5 mg TABLETS	Sandoz Canada Inc.	02337436	JE2529	July 2021	May 30, 2021
Sandoz IRBESARTAN HCT 300/12.5 mg TABLETS	Sandoz Canada Inc.	02337436	JK7459	October 2021	May 30, 2021
Sandoz IRBESARTAN HCT 300/12.5 mg TABLETS	Sandoz Canada Inc.	02337436	JK7460	October 2021	May 30, 2021
Sandoz IRBESARTAN HCT 300/12.5 mg TABLETS	Sandoz Canada Inc.	02337436	JM3516	October 2021	May 30, 2021
Sandoz IRBESARTAN HCT 300/12.5 mg TABLETS	Sandoz Canada Inc.	02337436	JM3517	November 2021	May 30, 2021
Sandoz IRBESARTAN HCT 300/12.5 mg TABLETS	Sandoz Canada Inc.	02337436	JR7821	February 2022	May 30, 2021
Sandoz IRBESARTAN HCT 300/12.5 mg TABLETS	Sandoz Canada Inc.	02337436	JU7500	April 2022	May 30, 2021
Sandoz IRBESARTAN HCT 300/12.5 mg TABLETS	Sandoz Canada Inc.	02337436	JU7501	April 2022	May 30, 2021
Sandoz IRBESARTAN HCT 300/12.5 mg TABLETS	Sandoz Canada Inc.	02337436	JU7502	April 2022	May 30, 2021
Sandoz IRBESARTAN HCT 300/12.5 mg TABLETS	Sandoz Canada Inc.	02337436	JU7503	April 2022	May 30, 2021
Sandoz IRBESARTAN HCT 300/12.5 mg TABLETS	Sandoz Canada Inc.	02337436	JY0147	April 2022	May 30, 2021
Sandoz IRBESARTAN HCT 300/12.5 mg TABLETS	Sandoz Canada Inc.	02337436	JM4631	November 2021	May 30, 2021
Sandoz IRBESARTAN HCT 300/12.5 mg TABLETS	Sandoz Canada Inc.	02337436	JZ2686	April 2022	May 30, 2021
Sandoz IRBESARTAN HCT 300/25 mg TABLETS	Sandoz Canada Inc.	02337444	JB0221	May 2021	May 30, 2021
Sandoz IRBESARTAN HCT 300/25 mg TABLETS	Sandoz Canada Inc.	02337444	JB0222	May 2021	May 30, 2021
Sandoz IRBESARTAN HCT 300/25 mg TABLETS	Sandoz Canada Inc.	02337444	JC4402	June 2021	May 30, 2021
Sandoz IRBESARTAN HCT 300/25 mg TABLETS	Sandoz Canada Inc.	02337444	JC4404	June 2021	May 30, 2021
Sandoz IRBESARTAN HCT 300/25 mg TABLETS	Sandoz Canada Inc.	02337444	JH2487	June 2021	May 30, 2021
Sandoz IRBESARTAN HCT 300/25 mg TABLETS	Sandoz Canada Inc.	02337444	JR7112	January 2022	May 30, 2021
Sandoz IRBESARTAN HCT 300/25 mg TABLETS	Sandoz Canada Inc.	02337444	JR7833	January 2022	May 30, 2021
Sandoz IRBESARTAN HCT 300/25 mg TABLETS	Sandoz Canada Inc.	02337444	JU3181	February 2022	May 30, 2021
Sandoz IRBESARTAN HCT 300/25 mg TABLETS	Sandoz Canada Inc.	02337444	JW9512	May 2022	May 30, 2021
Sandoz IRBESARTAN HCT 300/25 mg TABLETS	Sandoz Canada Inc.	02337444	JW9513	May 2022	May 30, 2021
Sandoz IRBESARTAN HCT 300/25 mg TABLETS	Sandoz Canada Inc.	02337444	KC1750	August 2022	May 30, 2021
Sandoz IRBESARTAN HCT 300/25 mg TABLETS	Sandoz Canada Inc.	02337444	JE1833	June 2021	May 30, 2021
Sandoz IRBESARTAN HCT 300/25 mg TABLETS	Sandoz Canada Inc.	02337444	JR8726	January 2022	May 30, 2021
Losartan
AURO-LOSARTAN 100 mg TABLETS	Auro Pharma Inc.	02403358	WB1019001- A	14 August 2022	May 30, 2021
AURO-LOSARTAN 100 mg TABLETS	Auro Pharma Inc.	02403358	WB1019001- B	14 August 2022	May 30, 2021
AURO-LOSARTAN 25 mg TABLETS	Auro Pharma Inc.	02403323	WB2519001- A	14 August 2022	May 30, 2021
AURO-LOSARTAN 50 mg TABLETS	Auro Pharma Inc.	02403331	WB5019001- A	14 August 2022	May 30, 2021
AURO-LOSARTAN 50 mg TABLETS	Auro Pharma Inc.	02403331	WB5019001- B	14 August 2022	May 30, 2021
LOSARTAN /TABLET/100 mg	Sivem Pharmaceuticals ULC	02388812	2151119	November 2023	May 30, 2021
LOSARTAN /TABLET/25 mg	Sivem Pharmaceuticals ULC	02388790	0080620	June 2023	May 30, 2021
LOSARTAN /TABLET/25 mg	Sivem Pharmaceuticals ULC	02388790	0090620	June 2023	May 30, 2021
LOSARTAN/TABLET/100 mg	Sivem Pharmaceuticals ULC	02388812	2101018	October 2021	May 30, 2021
LOSARTAN/TABLET/100 mg	Sivem Pharmaceuticals ULC	02388812	2020219	February 2022	May 30, 2021
LOSARTAN/TABLET/100 mg	Sivem Pharmaceuticals ULC	02388812	2030219	February 2022	May 30, 2021
LOSARTAN/TABLET/100 mg	Sivem Pharmaceuticals ULC	02388812	2040219	February 2022	May 30, 2021
LOSARTAN/TABLET/100 mg	Sivem Pharmaceuticals ULC	02388812	2090619	June 2022	May 30, 2021
LOSARTAN/TABLET/100 mg	Sivem Pharmaceuticals ULC	02388812	2100919	September 2022	May 30, 2021
LOSARTAN/TABLET/100 mg	Sivem Pharmaceuticals ULC	02388812	2110919	September 2022	May 30, 2021
LOSARTAN/TABLET/100 mg	Sivem Pharmaceuticals ULC	02388812	2120919	September 2022	May 30, 2021
LOSARTAN/TABLET/100 mg	Sivem Pharmaceuticals ULC	02388812	2130919	September 2022	May 30, 2021
LOSARTAN/TABLET/100 mg	Sivem Pharmaceuticals ULC	02388812	2050420	April 2023	May 30, 2021
LOSARTAN/TABLET/100 mg	Sivem Pharmaceuticals ULC	02388812	2060420	April 2023	May 30, 2021
LOSARTAN/TABLET/100 mg	Sivem Pharmaceuticals ULC	02388812	2070817	August 2021	May 30, 2021
LOSARTAN/TABLET/100 mg	Sivem Pharmaceuticals ULC	02388812	2040218	February 2022	May 30, 2021
LOSARTAN/TABLET/100 mg	Sivem Pharmaceuticals ULC	02388812	2140919	September 2023	May 30, 2021
LOSARTAN/TABLET/25 mg	Sivem Pharmaceuticals ULC	02388790	0050919	September 2022	May 30, 2021
LOSARTAN/TABLET/25 mg	Sivem Pharmaceuticals ULC	02388790	0060919	September 2022	May 30, 2021
LOSARTAN/TABLET/25 mg	Sivem Pharmaceuticals ULC	02388790	0070919	September 2022	May 30, 2021
LOSARTAN/TABLET/25 mg	Sivem Pharmaceuticals ULC	02388790	0080919	September 2022	May 30, 2021
LOSARTAN/TABLET/25 mg	Sivem Pharmaceuticals ULC	02388790	0080919A	September 2022	May 30, 2021
LOSARTAN/TABLET/25 mg	Sivem Pharmaceuticals ULC	02388790	0101019	October 2022	May 30, 2021
LOSARTAN/TABLET/25 mg	Sivem Pharmaceuticals ULC	02388790	0101019A	October 2022	May 30, 2021
LOSARTAN/TABLET/25 mg	Sivem Pharmaceuticals ULC	02388790	0030120	January 2023	May 30, 2021
LOSARTAN/TABLET/25 mg	Sivem Pharmaceuticals ULC	02388790	0040120	January 2023	May 30, 2021
LOSARTAN/TABLET/50 mg	Sivem Pharmaceuticals ULC	02388804	1121018	October 2021	May 30, 2021
LOSARTAN/TABLET/50 mg	Sivem Pharmaceuticals ULC	02388804	1131018	October 2021	May 30, 2021
LOSARTAN/TABLET/50 mg	Sivem Pharmaceuticals ULC	02388804	1130819	August 2022	May 30, 2021
LOSARTAN/TABLET/50 mg	Sivem Pharmaceuticals ULC	02388804	1140819	August 2022	May 30, 2021
LOSARTAN/TABLET/50 mg	Sivem Pharmaceuticals ULC	02388804	1150819	August 2022	May 30, 2021
LOSARTAN/TABLET/50 mg	Sivem Pharmaceuticals ULC	02388804	1160819	August 2022	May 30, 2021
LOSARTAN/TABLET/50 mg	Sivem Pharmaceuticals ULC	02388804	1180919	September 2022	May 30, 2021
LOSARTAN/TABLET/50 mg	Sivem Pharmaceuticals ULC	02388804	1070220	February 2023	May 30, 2021
LOSARTAN/TABLET/50 mg	Sivem Pharmaceuticals ULC	02388804	1080220	February 2023	May 30, 2021
LOSARTAN/TABLET/50 mg	Sivem Pharmaceuticals ULC	02388804	1090220	February 2023	May 30, 2021
LOSARTAN/TABLET/50 mg	Sivem Pharmaceuticals ULC	02388804	1100220	February 2023	May 30, 2021
LOSARTAN/TABLET/50 mg	Sivem Pharmaceuticals ULC	02388804	1110220	February 2023	May 30, 2021
LOSARTAN/TABLET/50 mg	Sivem Pharmaceuticals ULC	02388804	1060220	February 2023	May 30, 2021
LOSARTAN/TABLET/50 mg	Sivem Pharmaceuticals ULC	02388804	1170919	September 2023	May 30, 2021
LOSARTAN/TABLET/50 mg	Sivem Pharmaceuticals ULC	02388804	1120620	June 2024	May 30, 2021
LOSARTAN/TABLET/50 mg	Sivem Pharmaceuticals ULC	02388804	1010419	April 2022	August 28, 2021
LOSARTAN/TABLET/50 mg	Sivem Pharmaceuticals ULC	02388804	1020419	April 2022	August 28, 2021
Teva-Losartan 100 mg tablets	Teva Canada Ltd.	02357976	2050419	April 2022	August 28, 2021
Teva-Losartan 50 mg tablets	Teva Canada Ltd.	02357968	1070917	September 2021	August 28, 2021
Teva-Losartan 50 mg tablets	Teva Canada Ltd.	02357968	1020419	April 2022	August 28, 2021
Teva-Losartan 50 mg tablets	Teva Canada Ltd.	02357968	1030419	April 2022	August 28, 2021
Teva-Losartan 25 mg tablets	Teva Canada Ltd.	02380838	0040917	September 2021	August 28, 2021
TEVA-LOSARTAN 100 mg TABLETS	Teva Canada Ltd.	02357976	2010219	February 2022	May 30, 2021
TEVA-LOSARTAN 100 mg TABLETS	Teva Canada Ltd.	02357976	2010420	April 2023	May 30, 2021
TEVA-LOSARTAN 100 mg TABLETS	Teva Canada Ltd.	02357976	2020219	February 2022	May 30, 2021
TEVA-LOSARTAN 100 mg TABLETS	Teva Canada Ltd.	02357976	2020420	April 2023	May 30, 2021
TEVA-LOSARTAN 100 mg TABLETS	Teva Canada Ltd.	02357976	2030420	April 2023	May 30, 2021
TEVA-LOSARTAN 100 mg TABLETS	Teva Canada Ltd.	02357976	2040219	February 2022	May 30, 2021
TEVA-LOSARTAN 100 mg TABLETS	Teva Canada Ltd.	02357976	2060419	April 2022	May 30, 2021
TEVA-LOSARTAN 100 mg TABLETS	Teva Canada Ltd.	02357976	2080619	June 2022	May 30, 2021
TEVA-LOSARTAN 100 mg TABLETS	Teva Canada Ltd.	02357976	2080918	September 2021	May 30, 2021
TEVA-LOSARTAN 100 mg TABLETS	Teva Canada Ltd.	02357976	2091018	October 2021	May 30, 2021
TEVA-LOSARTAN 100 mg TABLETS	Teva Canada Ltd.	02357976	2101018	October 2021	May 30, 2021
TEVA-LOSARTAN 100 mg TABLETS	Teva Canada Ltd.	02357976	2161119	November 2022	May 30, 2021
TEVA-LOSARTAN 100 mg TABLETS	Teva Canada Ltd.	02357976	2171119	November 2022	May 30, 2021
TEVA-LOSARTAN 100 mg TABLETS	Teva Canada Ltd.	02357976	2030218	February 2022	May 30, 2021
TEVA-LOSARTAN 100 mg TABLETS	Teva Canada Ltd.	02357976	2070419	April 2023	May 30, 2021
TEVA-LOSARTAN 100 mg TABLETS	Teva Canada Ltd.	02357976	2181119	November 2023	May 30, 2021
TEVA-LOSARTAN 100 mg TABLETS	Teva Canada Ltd.	02357976	2191119	November 2023	May 30, 2021
TEVA-LOSARTAN 100 mg TABLETS	Teva Canada Ltd.	02357976	2140919	September 2023	May 30, 2021
TEVA-LOSARTAN 25 mg TABLETS	Teva Canada Ltd.	02380838	0010219	February 2022	May 30, 2021
TEVA-LOSARTAN 25 mg TABLETS	Teva Canada Ltd.	02380838	0020419	April 2022	May 30, 2021
TEVA-LOSARTAN 25 mg TABLETS	Teva Canada Ltd.	02380838	0030419	April 2022	May 30, 2021
TEVA-LOSARTAN 25 mg TABLETS	Teva Canada Ltd.	02380838	0031018	October 2021	May 30, 2021
TEVA-LOSARTAN 25 mg TABLETS	Teva Canada Ltd.	02380838	0040120	January 2023	May 30, 2021
TEVA-LOSARTAN 25 mg TABLETS	Teva Canada Ltd.	02380838	0040919	September 2022	May 30, 2021
TEVA-LOSARTAN 25 mg TABLETS	Teva Canada Ltd.	02380838	0050620	June 2023	May 30, 2021
TEVA-LOSARTAN 25 mg TABLETS	Teva Canada Ltd.	02380838	0050919	September 2022	May 30, 2021
TEVA-LOSARTAN 25 mg TABLETS	Teva Canada Ltd.	02380838	0060620	June 2023	May 30, 2021
TEVA-LOSARTAN 25 mg TABLETS	Teva Canada Ltd.	02380838	0070620	June 2023	May 30, 2021
TEVA-LOSARTAN 25 mg TABLETS	Teva Canada Ltd.	02380838	0010120	January 2024	May 30, 2021
TEVA-LOSARTAN 25 mg TABLETS	Teva Canada Ltd.	02380838	0020120	January 2024	May 30, 2021
TEVA-LOSARTAN 50 mg TABLETS	Teva Canada Ltd.	02357968	1040120	January 2023	May 30, 2021
TEVA-LOSARTAN 50 mg TABLETS	Teva Canada Ltd.	02357968	1030120	January 2023	May 30, 2021
TEVA-LOSARTAN 50 mg TABLETS	Teva Canada Ltd.	02357968	1040419	April 2022	May 30, 2021
TEVA-LOSARTAN 50 mg TABLETS	Teva Canada Ltd.	02357968	1050419	April 2022	May 30, 2021
TEVA-LOSARTAN 50 mg TABLETS	Teva Canada Ltd.	02357968	1060419	April 2022	May 30, 2021
TEVA-LOSARTAN 50 mg TABLETS	Teva Canada Ltd.	02357968	1070419	April 2022	May 30, 2021
TEVA-LOSARTAN 50 mg TABLETS	Teva Canada Ltd.	02357968	1080918	September 2021	May 30, 2021
TEVA-LOSARTAN 50 mg TABLETS	Teva Canada Ltd.	02357968	1090819	August 2022	May 30, 2021
TEVA-LOSARTAN 50 mg TABLETS	Teva Canada Ltd.	02357968	1090918	September 2021	May 30, 2021
TEVA-LOSARTAN 50 mg TABLETS	Teva Canada Ltd.	02357968	1100819	August 2022	May 30, 2021
TEVA-LOSARTAN 50 mg TABLETS	Teva Canada Ltd.	02357968	1101018	October 2021	May 30, 2021
TEVA-LOSARTAN 50 mg TABLETS	Teva Canada Ltd.	02357968	1110819	August 2022	May 30, 2021
TEVA-LOSARTAN 50 mg TABLETS	Teva Canada Ltd.	02357968	1111018	October 2021	May 30, 2021
TEVA-LOSARTAN 50 mg TABLETS	Teva Canada Ltd.	02357968	1121018	October 2021	May 30, 2021
TEVA-LOSARTAN 50 mg TABLETS	Teva Canada Ltd.	02357968	1130819	August 2022	May 30, 2021
TEVA-LOSARTAN 50 mg TABLETS	Teva Canada Ltd.	02357968	1180919	September 2022	May 30, 2021
TEVA-LOSARTAN 50 mg TABLETS	Teva Canada Ltd.	02357968	1010120	January 2024	May 30, 2021
TEVA-LOSARTAN 50 mg TABLETS	Teva Canada Ltd.	02357968	1030218	February 2022	May 30, 2021
TEVA-LOSARTAN 50 mg TABLETS	Teva Canada Ltd.	02357968	1080419	April 2023	May 30, 2021
TEVA-LOSARTAN 50 mg TABLETS	Teva Canada Ltd.	02357968	1120819	August 2023	May 30, 2021
TEVA-LOSARTAN 50 mg TABLETS	Teva Canada Ltd.	02357968	1141018	October 2022	May 30, 2021
Valsartan
Sandoz Valsartan 160 mg TABLETS	Sandoz Canada Inc.	02356767	KT9598	March 2023	May 30, 2021
Sandoz Valsartan 320 mg TABLETS	Sandoz Canada Inc.	02356775	KT8923	April 2023	May 30, 2021
Sandoz Valsartan 320 mg TABLETS	Sandoz Canada Inc.	02356775	KV6185	March 2023	May 30, 2021
Sandoz Valsartan 80 mg TABLETS	Sandoz Canada Inc.	02356759	KT7180	March 2023	May 30, 2021
Sandoz Valsartan 80 mg TABLETS	Sandoz Canada Inc.	02356759	KT9515	April 2023	May 30, 2021
VALSARTAN 160 mg TABLETS	Sanis Health Inc.	02366967	KT9597	March 2023	May 30, 2021

 Également disponible en français

SOURCE Health Canada

Media Enquiries: Health Canada, [phone], [email protected]; Public Enquiries: [phone], 1-866 225-0709, [email protected]